EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Future telling using nanovesicles: brain-derived, blood harvested extracellular vesicles for predicting human cognition fate

Ewa Kozela

Pharmacological Reports · 17.11.2026

DOI: 10.1007/s43440-026-00929-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacological Reports, online erschienen am 17.11.2026. Verfasst von Ewa Kozela. Beteiligte Einrichtung: Department of Affective Cognitive Neuroscience, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland. Ewa.koz…. Die Arbeit nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human brain remains difficult to study due to its limited accessibility. The limited access constrains mechanistic insight into human cognition, one of the core functions of the central nervous system (CNS). Although advances in neuroimaging and molecular profiling have refined our understanding of the CNS complexity, the molecular correlates of cognitive functions in humans across the lifespan still remain obscure. In this context, blood-circulating extracellular vesicles (EVs) of the CNS origin have emerged as a promising approach to interrogate brain biology in vivo. CNS-derived EVs retain cell-type-enriched cargo and can cross the blood-brain barrier, making them attractive candidates for a “liquid biopsy” biomarkers of synaptic integrity, neuroglial interactions, and early neurodegenerative changes. Accumulating evidence indicates that peripheral EV cargo is related to cognitive status and may distinguish individuals at risk of cognitive impairment from those who remain resilient. This distinction may be potentially based on EV-encapsulated synaptic proteins, neuroinflammatory mediators, or disease-associated tau and amyloidβ species. Moreover, EV-based measures may provide a tractable framework for aligning preclinical and clinical data, linking neuroglial mechanisms and task performance in animal models with cognitive trajectories in human longitudinal cohorts. This perspective mini-review evaluates the potential of the CNS-derived EVs circulating in peripheral blood as biomarkers of life-long cognitive states across neurodevelopment, adulthood, and aging. I discuss evidence that EV cargo profiles change across the lifespan and may capture dynamic shifts in synaptic function and network vulnerability. The article outlines key barriers to clinical translation, including challenges in standardizing EV isolation and characterization in line with MISEV guidelines, issues of reproducibility and cell-type attribution, and the need for integrated multi-omic and multimodal approaches to improve the specificity and predictive value of EV-based cognitive biomarkers. Not applicable.

Schlagwörter

Stichwörter der Autor:innen

AgingBiomarkerCentral nervous systemCognitionExtracellular vesicles

Autor:innen und Institutionen

  • Department of Affective Cognitive Neuroscience, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland. Ewa.kozela@if-pan.edu.pl.

Förderung

  • Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Zitieren

APA

Kozela, E. (2026). Future telling using nanovesicles: brain-derived, blood harvested extracellular vesicles for predicting human cognition fate. Pharmacological Reports. https://doi.org/10.1007/s43440-026-00929-4

Vancouver

Kozela E. Future telling using nanovesicles: brain-derived, blood harvested extracellular vesicles for predicting human cognition fate. Pharmacological Reports. 2026. doi:10.1007/s43440-026-00929-4

BibTeX
@article{Kozela2026,
  author = {Kozela, Ewa},
  title = {Future telling using nanovesicles: brain-derived, blood harvested extracellular vesicles for predicting human cognition fate},
  journal = {Pharmacological Reports},
  year = {2026},
  doi = {10.1007/s43440-026-00929-4}
}
Kostenlos starten →